Literature DB >> 7912351

What is the rationale for growth hormone therapy in Turner's syndrome?

S Cianfarani1, F Vaccaro, B Boscherini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7912351     DOI： 10.1016/s0140-6736(94)91288-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  New peptide and protein drugs.

Authors:  P Vermeij; D Blok
Journal:  Pharm World Sci       Date:  1996-06

2.  'Short stature in children--a questionnaire for parents': a new instrument for growth disorder-specific psychosocial adaptation in children.

Authors:  F Haverkamp; M Noeker
Journal:  Qual Life Res       Date:  1998-07       Impact factor: 4.147

Review 3.  The Rationale for Growth Hormone Therapy in Children with Short Stature.

Authors:  Annalisa Deodati; Stefano Cianfarani
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.